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Abstract 
Background: Cornelia de Lange Syndrome (CdLS) is a rare congenital disorder characterized by typical facial 
features, growth failure, limb abnormalities, and gastroesophageal dysfunction that may be caused by mutations in 
several genes that disrupt gene regulation early in development. Symptoms in individuals with CdLS suggest that the 
peripheral nervous system (PNS) is involved, yet there is little direct evidence.
Method: Somatic nervous system was evaluated by conventional motor and sensory nerve conduction studies and 
autonomic nervous system by heart rate variability, sympathetic skin response and sudomotor testing. CdLS Clinical 
Score and genetic studies were also obtained.
Results: Sympathetic skin response and sudomotor test were pathological in 35% and 34% of the individuals with 
CdLS, respectively. Nevertheless, normal values in large fiber nerve function studies.
Conclusions: Autonomic nervous system (ANS) dysfunction is found in many individuals with Cornelia de Lange 
Syndrome, and could be related to premature aging.
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Background
Cornelia de Lange Syndrome (CdLS) is a genetic disease 
due to spontaneous mutations in genes of the cohesin 
protein complex, mainly NIPBL, in 70% of the cases [1–4] 
and SMC1A, SMC3, RAD21, BRD4, HDAC8, ANKRD11 
and MAU2 [5–9]. Manifestations of the syndrome dif-
fer with mutated gene type, with variants in NIPBL often 
associated with more severe clinical phenotype. The syn-
drome is characterized by typical facial features, growth 
failure, limb abnormalities and the involvement of many 
organs and systems including the central nervous system. 
Sweating abnormalities, abnormal reactions to cold and 
heat, and severe gastrointestinal reflux are also prevalent 
and suggest a compromised peripheral nervous system 
[1]. More than 80% of individuals with CdLS have some 
autonomic nervous system dysfunction, while 26% of 
those have moderate to severe dysfunction as measured 
by the Compass-31 questionnaire, a validated survey tool 
for autonomic dysfunction [10]. The aim of this study was 
to get new insights into neuronal dysfunction in CdLS 
by analyzing large and small fiber nerves with different 
techniques.
Patients and methods
All the peripheral nervous system studies, except the 
sudomotor test, were made in a group of 20 individuals 
with CdLS (7 male, 13 female, aged 3–37  years). In the 
sudomotor test the population was broadened to 47 indi-
viduals with CdLS (18 male, 29 female, aged 1.5–42 years) 
and 50 slightly older healthy controls (18 male, 32 female, 
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aged 7–48  years). All of the individuals with CdLS and 
controls were Caucasian, except 3 Latino and 1 Middle 
East subjects in the CdLS group. The protocol study was 
approved by the Ethics Committee of Clinical Research 
from the Government of Aragón (CEICA;PI16/225). All 
the individuals with CdLS and controls gave informed 
consent for their participation.
To evaluate the somatic peripheral nervous system, 
conventional motor and sensory nerve conduction stud-
ies [11–15] were carried out in upper and lower limbs 
(large fiber nerves).
The autonomic nervous system (small fibre nerves) was 
studied by means of heart rate variability at rest, sympa-
thetic skin response and sudomotor test. Heart rate vari-
ability (HRV) at rest was evaluated recording the heart 
rate for 5 min [16]. Sympathetic skin response (SSR) was 
studied with electric stimuli over the Median and Poste-
rior Tibial nerves, recording the responses over the palm 
of both hands (Median) and the sole of both feet (Tibial) 
[17, 18]. Nerve conduction studies, HRV and SSR were 
performed by the same group of neurophysiologists with 
a 5-channel Natus® Electromyography equipment. The 
sudomotor test, which gives the number of functioning 
sweat glands per  cm2 (sweat gland density, SGD) was 
obtained on a silicone mold after pilocarpine iontophore-
sis stimulation over the foot dorsum [19].
Genetic studies were realized by standard Sanger 
sequencing and Next Generation Sequencing (NGS) pan-
els. Clinical severity score according to the first interna-
tional consensus statement [1] was also studied (Table 1). 
Statistical studies were achieved with the SPSS program 
version 25.
Results
Conventional motor and sensory nerve conduction stud-
ies (large fiber nerves) were normal in all 20 individu-
als with CdLS analyzed (Additional file  1: Tables  1–3). 
The study of the autonomic nervous system (small fiber 
nerves) in HRV at rest was normal as well (Table 2). Nev-
ertheless, SSR revealed mild alterations in lower limbs 
in 7 of the 20 individuals, with asymmetrical responses 
(Table 2, Fig. 1). Sudomotor tests evinced reduced SGD 
in 16 of the 47 individuals with CdLS regarding the con-
trol group by decades of life (Table  3). The regression 
analysis showed that, in spite of dispersion, there were 
two different populations, with statistically significant 
differences between the control group and individu-
als with CdLS (p < 0.05 and p < 0.01) (Fig.  2). The linear 
regression showed that the slope of the SGD reduction by 
age is much more pronounced in individuals with CdLS 
than in controls (Fig.  2). Independence samples T test 
showed the results of the mean differences of the sweat 
gland density (SGD) by age group, with reduction in the 
SGD more evident in the individuals with variants in 
NIPBL than in the controls (p < 0.01). These differences 
were found in the whole NIPBL group as in all the dec-
ades of life, except the first one (Fig. 2, Table 4).
Genetic studies of the 47 individuals with CdLS 
revealed 31 with variants in NIPBL, 4 in SMC1A, 2 in 
RAD21, 2 in HDAC8 and 1 in SMC3 and negative in 7 
individuals (Table 3). In Table 3 there are the CdLS Clini-
cal Scores [1]. No relationship between clinical score or 
gastroesophageal reflux disease (GERD) and findings 
of the sudomotor test was found. In Additional file  1: 
Table  4 is shown the SGD in the control group by dec-
ades of life.
Discussion
Though the clinical manifestations of CdLS suggest that 
the peripheral nervous system is affected, large fiber 
nerve studies (conventional motor and sensory nerve 
conduction studies) are within normal limits. However, 
we have shown evidence, for the first time, for autonomic 
nervous system dysfunction in individuals with CdLS.
The sympathetic skin response reveals asymmetri-
cal pathological responses in lower limbs in 7 of the 20 
individuals (35%), with one of them affected in upper 
limbs as well. This could be considered a malformative 
manifestation of the syndrome. However, it is remark-
able that the asymmetry is more frequent in lower than 
in upper limbs, which are often more affected [1–4]. This 
asymmetry does not seem to be related to GERD or the 
Clinical Severity Score (CSS), yet all the individuals had 
mutations in the NIPBL gene (Table 2).
Sudomotor testing shows a reduction in the sweat 
gland density (SGD) in 16 of 47 (34%) of the analyzed 
individuals with CdLS. These data are further supported 
by a reduction of the number of sweat droplets imprinted 
on the silicone after pilocarpine iontophoresis as indirect 
evidence of decreased postganglionic sudomotor nerve 
fibers, compared to an unaffected population. Though 
sweat gland density decreases physiologically with aging, 
individuals with CdLS show a reduction much greater 
than should be expected by their age. This decrease is 
evident from the second decade of life, and is more pro-
nounced at older ages (Table 3, Fig. 2). All of this seems 
to strengthen the hypothesis that these patients have pre-
mature aging. Nevertheless, no relationships were found 
between SGD reduction and clinical score or GERD.
The reduction in the SGD is evident in individuals with 
mutations in NIPBL (Tables 3, 4), and seems to be similar 
in individuals with variants in SMC1A (3 of the 4 indi-
viduals with mutations in SMC1A had SGD reduction). 
However, individuals with variants in HDAC8 and RAD 
21 are in the first decade of life, so it is early to make an 
assessment. Surprisingly, there is a high value of sweat 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Page 4 of 8Pablo et al. Orphanet J Rare Dis          (2021) 16:458 
Table 2 Sympathetic skin response and heart rate variability in CdLS
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gland density in the only individual with an SMC3 muta-
tion, who is 39 years old. Regarding the ethnic distribu-
tion, only 4 individuals in the NIPBL group and none in 
the control group were not Caucasian, and all of them 
had normal values in SGD, though they were in the first 
decade of life. In the group of NIPBL, there is a repeated 
Table 2 (continued)
SSR Sympathetic Skin Response; HRV Heart Rate Variability; RMSSD Root Mean Square of Successive Differences. Lat latency; Amp Amplitude; ms milliseconds; µV 
microvolts; NE Not examined. P40 left arm not studied. P41 only cooperated for the SSR study in one hand. Asymmetrical: Used to indicate side-to-side differences in 
amplitude and/or morphology in the Sympathetic Skin Response (SSR) in both upper or lower limbs
A Electrical smulus in le hand    B Electrical smulus in right hand 
C Electrical smulus in le foot  D Electrical smulus in right foot
Responses in le hand
Responses in right hand
Responses in le hand
Responses in right hand
Responses in le foot Responses in le foot
Responses in right foot Responses in right foot
Fig. 1 Sympathetic Skin response in upper and lower limbs. A Normal symmetrical sympathetic skin response (SSR) in upper limbs in individual 
‑30‑ after electrical stimulus in left hand, recorded simultaneously in both hands. Upper curves refer to the left hand, lower curves refer to the 
right hand. B Pathological asymmetrical in amplitude and morphology SSR in upper limbs in individual ‑23‑ after electrical stimulus in right hand, 
recorded simultaneously in both hands. Upper curves refer to the left hand, lower curves refer to the right hand. C Normal symmetrical normal SSR 
in lower limbs in individual ‑30‑ after electrical stimulus in left foot, recorded simultaneously in both feet. Upper curves refer to the left foot, lower 
curves refer to the right foot. D Pathological symmetrical in amplitude SSR in lower limbs in individual ‑40‑ after electrical stimulus in right foot, 
recorded simultaneously in both feet. Upper curves refer to the left foot, lower curves refer to the right foot
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Table 3 Genetics, clinical score and sweat gland density (SGD) in individuals with CdLS in different decades of life.
Individuals are differentiated in decades of life by different shading colours from: white: 1st decade of life; light grey: 2nd decade of life; medium grey: 3rd 
decade of life; grey: 4th decade of life; dark grey: 5th decade of life. M male, F female, PNS Peripheral Nervous System, GERD Gastroesophageal reflux disease (– 
no, + mild, +  + moderate, +  +  + severe), SGD Sweat Gland Density: gland number/cm2
Fig. 2 Analysis of SGD. (SGD: sweat gland density: gland number/
cm2): each dot corresponds to a different individual at the indicated 
age. Filled dots are CdLS individuals (n = 47) and empty dots 
correspond to control individuals (n = 50). Lines show mean linear fit 
and 95% confidence intervals (shadowed areas). Significant non‑zero 
slope, linear regression, *p‑value < 0.05, **p‑value < 0.01
Table 4 SGD by decades of life
Values for sweat gland density in CdLS individuals with variants in NIPBL and 
controls by groups of age
a Independent samples t test. There are statistically significant differences 
(p < 0.05) in the SGD global mean (control group compared to the global NIPBL 
group) and by decades of life, in all the decades except in the first one
Controls N CdLS NIPBL N pa
Mean SGD (g/cm2) ± SD 217.60 ± 30.61 50 178.03 ± 72.53 27 0.001
Mean SGD (g/cm2) ± SD 
by decades of life
Controls N CdLS NIPBL N pa
 ≤ 10 years 236.76 ± 34.81 13 226.00 ± 86.60 10 0.686
11–20 years 217.18 ± 29.99 11 159.09 ± 45.35 11 0.002
21–30 years 206.40 ± 22.9 10 139.00 ± 59.90 3 0.010
31–40 years 215.28 ± 32.40 8 143.00 ± 22.62 2 0.013
41–50 years 202.50 ± 22.16 8 94.0 1 0.002
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mutation, a frameshift mutation in 2 siblings. According 
to the asymmetry in the SSR response, 3 of the NIPBL 
individuals had missense mutations, 2 of them frameshift 
mutations and 1 of them splicing mutation, but the num-
ber of individuals is not big enough to do a correlation 
with the autonomic neuropathy. Further studies are war-
ranted to look at autonomic nervous system dysfunction 
and relation to mutated gene and age in individuals with 
CdLS.
Conclusion
Individuals with CdLS have abnormal autonomic nerv-
ous system function, showing asymmetries in the sympa-
thetic responses in lower limbs, and pathological results 
in the sudomotor test. The degree of dysfunction in post-
ganglionic sudomotor nerve fibers might be related to 
premature aging. Even though, somatic nervous system 
function studies were normal.
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